Strand signs up Gene Tech Company for distribution of its flagship product, avadis in China and Hong Kong

13-Sep-2004

Bangalore, India. Strand Genomics, a Bangalore-based life sciences informatics company announced today that it has entered into distribution agreement with GeneTech Company for its product avadis in Hong Kong & China (PRC), a tool that brings the very best in data mining techniques and the finest in software engineering to microarray gene expression data analysis.

avadis combines scalable analytical algorithms with powerful and interactive visualization to derive valuable insights from the data. The uniqueness of avadis stems from the depth and versatility of its capabilities in accessing, visualizing and analyzing gene expression data. avadis has the ability to seamlessly access and import data from various sources. avadis has easy to use wizards to import Affymetrix files including from GCOS. Wizards are also available to support data from spotted arrays. It also provides a wide range of clustering techniques and statistical tests that make up the complete analysis toolset. avadis is a comprehensive solution that meets all the needs of gene expression researchers with a superior performance-to-price feature. avadis is available in three editions - explorer, prophetic and pride.

With the launch of the 863 Program in 1986, biotechnology has been identified as one of the rapidly growing areas in China. Funding from the Chinese Government to various biotech sectors, including but not limited to Biochip, Gene Medicine and Gene Treatment, exceeded $300 million in year 2000 and is increasing annually. Funding source is now extended to private sectors and venture capitalists.

"Facing the bloom of biotech research activities, processing of huge and diversified biological data efficiently and accurately will become very challenging. Gene Tech visualizes the increase in demand for a 'user-friendly' and professional type of statistics tool. The unique features in visualization, data handling, data mining and data analysis carried by avadis, together with its competitive price should provide a complete solution for both academic researchers and industrial customers in China." said Deborah Au, Project Manager, Gene Tech Company.

"We are very pleased to announce this new partnership with Gene Tech." said Vijay Chandru, Ph.D., CEO of Strand Genomics. "We feel that there is a natural fit between avadis and the current products being handled by Gene Tech. We will be doing joint road shows soon to make this market aware of the potential of avadis and how it fits into their analysis workflow"

https://www.bionity.com/en/news/39571/strand-signs-up-gene-tech-company-for-distribution-of-its-flagship-product-avadis-in-china-and-hong-kong.html